Results 131 to 140 of about 14,148 (238)

Insight into Inhibitory Mechanism of PDE4D by Dietary Polyphenols Using Molecular Dynamics Simulations and Free Energy Calculations. [PDF]

Biomolecules, 2021
Furlan V, Bren U.
europepmc   +1 more source

Razvoj osebnosti in vseživljenjsko izobraževanje

, 2000
Irena Lesar
openalex   +1 more source

Analiza dejavnikov, ki vplivajo na motiviranost brezposelnih za izobraževanje

, 2003
Marko Radovan
openalex   +2 more sources

Effects of L-dopa on expression of prolactin and synaptotagmin IV in 17-beta-estradiol-induced prolactinomas of ovariectomized hemiparkinsonian rats. [PDF]

Bosn J Basic Med Sci, 2021
Zorovic M, Kolmančič K, Živin M.
europepmc   +1 more source

Izobraževanje in usposabljanje učiteljev s poudarkom na učiteljih slovenščine

Slovenika časopis za kulturu nauku i obrazovanje = časopis za kulturo znanost in izobraževanje, 2021
M. Kovač
semanticscholar   +1 more source

Poklicni razvoj učitelja v osnovni šoli [PDF]

, 2015
Moretti, Adi, Moretti, Melita, Ropar, Ivan   +2 more
core   +1 more source

Hanseniaspora smithiae sp. nov., a Novel Apiculate Yeast Species From Patagonian Forests That Lacks the Typical Genomic Domestication Signatures for Fermentative Environments. [PDF]

Front Microbiol, 2021
Čadež N, Bellora N, Ulloa R, Tome M, Petković H, Groenewald M, Hittinger CT, Libkind D.   +7 more
europepmc   +1 more source

Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting. [PDF]

J Alzheimers Dis
Wimo A, Handels R, Blennow K, Kirsebom BE, Selnes P, Bon J, Emersic A, Gonzalez-Ortiz F, Gregoric Kramberger M, Sköldunger A, Speh A, Timón-Reina S, Vromen E, Jelle Visser P, Winblad B, Fladby T.   +15 more
europepmc   +1 more source

Inhibition of the SARS-CoV-2 3CL^pro main protease by plant polyphenols. [PDF]

Food Chem, 2022
Bahun M, Jukić M, Oblak D, Kranjc L, Bajc G, Butala M, Bozovičar K, Bratkovič T, Podlipnik Č, Poklar Ulrih N.   +9 more
europepmc   +1 more source

Non-clinical evaluation of pmIL12 gene therapy for approval of the phase I clinical study. [PDF]

Sci Rep
Markelc B, Jesenko T, Kranjc Brezar S, Omerzel M, Lampreht Tratar U, Rencelj A, Matkovic U, Znidar K, Kos S, Levpuscek K, Pisljar Z, Kesar U, Komel T, Bozic T, Tuljak A, Hudej R, Peterka M, Kamensek U, Cör A, Gasljevic G, Nemec Svete A, Tozon N, Sersa G, Cemazar M.   +23 more
europepmc   +1 more source